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166Objective: The Norwood procedure, the first surgical step of staged palliation for hypoplastic left heart syn-
drome, is also applied for other complex single-ventricle lesions with systemic outflow tract obstruction or aortic
arch hypoplasia. We reviewed our 15-year institutional experiencewith the Norwood procedure for patients with
and without hypoplastic left heart syndrome.
Methods: A total of 41 patients without hypoplastic left heart syndrome and 212 patients with hypoplastic left
heart syndromewho underwent a Norwood procedure between January 1996 and December 2010 were enrolled.
Full medical records were reviewed to assess the determinants of outcome.
Results: Early failure (death or cardiac transplantation) was 7% in patients without hypoplastic left heart syn-
drome and 13% in patients with hypoplastic left heart syndrome (P¼ .29). Frequency of postoperative compli-
cations, duration of postoperative ventilation, and length of vasoactive drug treatment were not different between
groups. Transplant-free survival until the second operative step trended to be higher for patients without hypo-
plastic left heart syndrome (92% vs 80%, P ¼ .067). Recurrent aortic arch obstruction was more common in
patients without hypoplastic left heart syndrome (15/39 vs 32/171, P¼ .008), but there were 4 patients with ste-
nosis of the proximal aortic arch. In subsequent procedures, 31 patients without hypoplastic left heart syndrome
underwent superior cavopulmonary anastomosis and 5 biventricular repair. Overall transplant-free survival was
not different between groups (P ¼ .119) but trended to be higher in patients with a systemic or substantial left
ventricle remnant contributing to cardiac output (P ¼ .082).
Conclusions: Early and long-term survivals and postoperative complications were similar between patients with
and without hypoplastic left heart syndrome undergoing a Norwood operation. Recurrent aortic arch obstruction
was common in both groups but more prevalent in patients without hypoplastic left heart syndrome. (J Thorac
Cardiovasc Surg 2012;144:166-72)The outcome for patients with hypoplastic left heart syn-
drome (HLHS) has dramatically improved over the past 2
decades because of refinement of surgical technique and
perioperative care.1-4 We recently reported our institutional
12-year experience with the Norwood procedure as first-
stage palliation for HLHS and noted a remarkable reduction
of early mortality within the study period.5,6
The Norwood procedure is also applied for other complex
single-ventricle lesions with severe systemic outflow tract
obstruction, including aortic arch hypoplasia (non-HLHS
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The Journal of Thoracic and Cardiovascular Surgand long-term outcome for this heterogeneous group of pa-
tients have been reported.7-10 We evaluated our 15-year
single-center outcome of the Norwood operation for com-
plex single-ventricle lesions in comparison with patients
with HLHS.MATERIALS AND METHODS
We reviewed our surgical database to identify patients who underwent
a modified Norwood procedure between January 1, 1996, and December
31, 2010. Patients with single-ventricle physiology who did not require aor-
tic arch reconstruction were excluded. Follow-up lasted until March 31,
2011. Patients with a functional single ventricle and systemic outflow tract
obstruction, including aortic arch hypoplasia not complying with the diag-
nostic criteria for HLHS, were classified as the non-HLHS group.11 For
these patients, the dominant systemic ventricle was determined by echocar-
diography, and the group was subdivided into patients with a right systemic
ventricle and patients with a systemic left ventricle. Patients with a domi-
nant right ventricle who had a substantial left ventricle contributing to car-
diac output were also assigned to the left ventricle group. Patients with
HLHSwere assigned to distinct anatomic subgroups (mitral and aortic atre-
sia, mitral atresia and aortic stenosis, mitral stenosis and aortic atresia, and
mitral and aortic stenosis) according to the echocardiography performed
before the Norwood operation.11 Full medical records were reviewed to as-
sess patient, hemodynamic, procedural, and morphologic determinants of
outcome. Informed consent for anonymized data analysis had beenery c July 2012
Abbreviations and Acronyms
DHCA ¼ deep hypothermic circulatory arrest
HLHS ¼ hypoplastic left heart syndrome
RVPA ¼ right ventricle to pulmonary artery
VSD ¼ ventricular septal defect
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Dobtained for every patient, and local ethics committee approval was waived
because of the retrospective nature of the study.
Preoperative Treatment
All patients were treated according to a standardized preoperative treat-
ment protocol with low-dose prostaglandin E1, afterload reduction with
sodium-nitroprusside or phentolamine. and avoidance of mechanical ven-
tilation or inotropic support.5
Norwood Operation
In our routine Norwood procedure, the pulmonary artery is transected at
the bifurcation. The arterial duct is ligated and divided, and ductal tissue is
completely excised from the aortic wall. Potential coarctation is resected.
The descending aorta is incised for approximately 5 mm, and the incision
is elongated longitudinally along the inner curvature deep into the aortic
root, which results in a short pre-coronary segment. The proximal end of
the pulmonary trunk is connected side-by-side with the diminutive ascend-
ing aorta. The aortic arch and ascending aorta are patch augmented and
connected with the circumference of the transected pulmonary artery to
construct the neoaorta. From 1996 to 1999, the aortic arch was augmented
with pulmonary homograft (non-HLHS, n ¼ 9; HLHS, n ¼ 32). Since
2000, bovine pericardium has been used.
The Norwood procedurewas slightly modified in some of the patients in
the non-HLHS group. Depending on the underlying anatomy and the size
of the native ascending aorta, the longitudinal incision along the aorta was
extended only up to the level of the transected pulmonary trunk, and then
both vessels were connected side by side. In the presence of transposed
great arteries, the longitudinal incision along the inner curvature of the aor-
tic arch was extended to the dorsal aspect of the ascending aorta. The ven-
tral side of the pulmonary trunk facing the ascending aorta was incised in
a v-shaped fashion and connected side by side with the native ascending
aorta.
A modified Blalock–Taussig shunt between the distal part of the innom-
inate artery and the patch-reconstructed pulmonary bifurcation provided
pulmonary blood flow in our standard Norwood procedure for the HLHS
and non-HLHS groups. A central aortopulmonary shunt was routinely
used in the presence of an aberrant right subclavian artery. Since 2004,
a right ventricle to pulmonary artery (RVPA) shunt was occasionally placed
in patients with lowweight or in patients in the non-HLHS group with a hy-
poplastic residual outlet chamber connected to the systemic ventricle by an
unrestrictive ventricular septal defect (VSD). Repair of associated defects
was performed as necessary. Selective cerebral perfusion during aortic arch
reconstruction was initiated in 2000 and has been used in all patients since
then. Routine primary chest closure was intended in all patients. Delayed
sternal closure was only performed in hemodynamically unstable patients.
Subsequent operative steps for the non-HLHS and HLHS groups in-
cluded a superior cavopulmonary anastomosis using the hemi-Fontan tech-
nique described by Bove,12 followed by a fenestrated Fontan operation
with an intra-atrial tunnel.
Postoperative Management
Our routine postoperative management has been described.5,6
Postoperative inotropic support was achieved with epinephrine andThe Journal of Thoracic and Caafterload reduction with sodium-nitroprusside or phentolamine. Beginning
in March 2010, epinephrine and milrinone were the only routinely used va-
soactive agents. The postoperative course was evaluated for the occurrence
of complications and the duration of mechanical ventilation and vasoactive
drug therapy.
Outcome Measures
Early failure after the Norwood operation was defined as death or car-
diac transplantation during the first 30 postoperative days or before dis-
charge from the hospital. Death or cardiac transplantation in discharged
patients occurring more than 30 days after the Norwood procedure and
before the second surgical step was referred to as interstage failure.
Postoperative complications were classified as cardiac complications (car-
diopulmonary resuscitation, arrhythmias, and shunt dysfunction) and non-
cardiac complications (sepsis and neurologic complications, eg, seizures,
cerebral hemorrhage, and cerebral infarct).5 The frequency of recurrent
aortic arch obstruction and the need for balloon angioplasty or surgical re-
intervention between the Norwood procedure and the second surgical step
were evaluated by reviewing cardiac catheterization reports. Recurrent aor-
tic arch obstruction was defined as a pressure gradient exceeding 20mmHg
or a localized narrowing regardless of the gradient. Systemic atrioventric-
ular valve regurgitation was assessed on the day before the second surgical
step and quantified using color Doppler techniques. The degree of regurgi-
tation was graded subjectively as absent, mild, mild to moderate, moderate
to severe, or severe.
Statistics
Statistical analyses were performed with the Statistical Package for the
Social Sciences 17.0 (SPSS Inc, Chicago, Ill). Continuous variables are
presented as mean and standard deviation or median and range as appropri-
ate; categoric data are displayed as number and percentages. Continuous
variables were analyzed with the Student t test for 2 independent samples
after testing for equality of variances of data with the Levene test. Nonpara-
metric data were analyzed with the Mann–Whitney U test. For categoric
data, the chi-square or Fisher exact test was applied. In addition, univariate
logistic regression analysis was used to evaluate continuous variables as
risk factors for early failure after the Norwood operation. For multivariate
analyses, variables with a P value of .1 or less on univariate analysis were
entered into a stepwise logistic regression model. Survival was calculated
with the Kaplan–Meier method and compared using the Breslow test.
RESULTS
Patient Characteristics
Overall, 41 patients (29 male, 12 female) in the non-
HLHS group and 212 patients (132 male, 80 female) in
the HLHS group were enrolled. Cardiac diagnoses of the
non-HLHS group are shown in Table 1. In the non-HLHS
group, 26 patients (63%) had a systemic left ventricle or
a substantial left ventricle remnant contributing to cardiac
output. The non-HLHS group included 3 patients in
whom an initial biventricular attempt failed (critical aortic
stenosis n ¼ 2, mitral valve hypoplasia n ¼ 1). One patient
received serial stenting of the hypoplastic aortic arch at an
outside hospital.
In the HLHS group, mitral and aortic atresia were ob-
served in 99 patients (47%), mitral and aortic stenosis
were observed in 50 patients (24%), mitral stenosis and aor-
tic atresia were observed in 50 patients (24%), and mitral
atresia and aortic stenosis were observed in 13 patients
(6%).rdiovascular Surgery c Volume 144, Number 1 167
TABLE 1. Cardiac anatomy in the non–hypoplastic left heart
syndrome group (n ¼ 41)
Cases with a systemic right ventricle (n ¼ 15)
Unbalanced atrio-VSD 6 (14.6%)
Mitral atresia or severe mitral stenosis 5 (12.2%)
Double-outlet right ventricle 3 (9.8%)
Critical aortic stenosis with aortic arch hypoplasia 1 (2.4%)
Cases with a systemic left or substantial left ventricle
remnant (n ¼ 26)
Double-inlet left ventricle with transposition of the
great arteries
7 (17.1%)
Tricuspid atresia with transposition of the great
arteries
4 (9.8%)
ccTGAwith tricuspid valve atresia/stenosis 2 (4.9%)
Criss-cross heart with transposition of the great
arteries
1 (2.4%)
Transposition of the great arteries with aortic atresia 1 (2.4%)
Transposition of the great arteries with interrupted
aortic arch
1 (2.4%)
Aortic atresia with VSD 8 (19.5%)
Double-outlet right ventricle 1 (2.4%)
Critical aortic stenosis with aortic arch hypoplasia 1 (2.4%)
VSD, Ventricular septal defect; ccTGA, congenitally corrected transposition of the
great arteries.
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the HLHS group (3.4  1.4 mm vs 4.9  2.1 mm,
P<.001). The ascending aorta diameter was 2 mm or less
in 8 patients (20%) in the non-HLHS group and in 44 pa-
tients (21%) in the HLHS group (P ¼ .86).
An aberrant right subclavian artery was found in 3 pa-
tients (7%) in the non-HLHS group and in 15 patients
(7%) in the HLHS group. Total anomalous pulmonary ve-
nous return was diagnosed in 1 patient in the non-HLHS
group and in 4 patients in the HLHS group. Four additional
patients with HLHS had partial anomalous pulmonary ve-
nous return.
An accompanying genetic syndrome was seen in 2 pa-
tients (5%) in the non-HLHS group and 5 patients (2%)
in the HLHS group. Prematurity accounted for 3 patients
(7%) in the non-HLHS group and 14 patients (7%) in the
HLHS group. Preoperative complications included necro-
tizing enterocolitis (non-HLHS: n ¼ 5, 12%; HLHS:
n¼ 10, 5%) and cardiac decompensation with signs of mul-
tiorgan failure (non-HLHS: n ¼ 1, 2%; HLHS: n ¼ 24,
11%) requiring resuscitation in 1 patient in the non-
HLHS group and 5 patients in the HLHS group.
Norwood Procedure
Table 2 shows data of the Norwood procedure and vari-
ables of the postoperative course compared between the
non-HLHS and HLHS groups. No differences in weight
and age at operation existed.
An RVPA shunt was more frequently used in the non-
HLHS group (non-HLHS: n ¼ 6, 15% vs HLHS: n ¼ 2,
1% P< .001). In the beginning of the study period, 12168 The Journal of Thoracic and Cardiovascular Surgpatients (29%) in the non-HLHS group and 40 patients
(19%) in the HLHS group underwent operation with deep
hypothermic circulatory arrest (DHCA) with a mean dura-
tion of 76  15 minutes and 71  16 minutes, respectively
(P¼ .36). Overall, the duration of cardiopulmonary bypass,
aortic crossclamp, DHCA, and total support time was not
different between the non-HLHS and HLHS groups, but
myocardial ischemia was longer in the non-HLHS group
(65  19 minutes vs 56  19 minutes, P ¼ .005).
Postoperative Course
Duration of postoperative mechanical ventilation, inotro-
pic support, and afterload reduction was not different
between the non-HLHS and HLHS groups (Table 2). Post-
operative complications were seen in 21 patients (51%) in
the non-HLHS group and 106 patients (50%) in the HLHS
group (P ¼ .89). Cardiopulmonary resuscitation accounted
for 6 (35%) and 39 (46%) of the cardiac complications in
the non-HLHS and HLHS groups, respectively (P ¼ .40).
Outcome After Norwood Operation
Early failure after the Norwood procedure was 12% for
the entire cohort, 7% for the non-HLHS group (3 early
deaths), and 13% for the HLHS group (27 early deaths, 1
cardiac transplantation) (P ¼ .29). The results of univariate
risk factor analysis are shown in Table 3. In a stepwise mul-
tivariate model, only longer duration of myocardial ische-
mia was associated with a higher risk for early failure
(odds ratio, 1.47; confidence interval, 1.11–1.94) per 15-
minute increase (P ¼ .007).
Interstage failure did not occur in the non-HLHS group
but did occur in 15 patients (8%) in the HLHS group
(P ¼ .14). Overall, transplant-free survival until the second
operative step was 92% for the non-HLHS group and 80%
for the HLHS group (P ¼ .067).
Recurrent Aortic Arch Obstruction
Between the Norwood operation and the subsequent sec-
ond operative step, 39 patients in the non-HLHS group and
171 patients in the HLHS group underwent cardiac cathe-
terization. Recurrent aortic arch obstruction was noted in
15 patients (38%) in the non-HLHS group and was signif-
icantly more common compared with the HLHS group,
with 32 cases (19%) (P ¼ .008). Although aortic arch ob-
struction in the HLHS group occurred in the aortic isthmus
region only, stenosis of the neoascending aorta or proximal
aortic arch developed in 4 patients in the non-HLHS group.
The patch material was not associated with an increased risk
for recurrent obstruction (pulmonary homograft: 6/35 vs
bovine pericardium: 41/175; P ¼ .42). In the non-HLHS
group, recurrent obstruction in cases with transposition of
the great arteries tended to be less common compared
with the remainder (4/18 vs 11/21, P ¼ .054) and included
stenosis of the proximal aortic arch in 1 case only.ery c July 2012
TABLE 2. Norwood procedure and postoperative course
non-HLHS (n ¼ 41) HLHS (n ¼ 212) P value
Norwood procedure
Median age (d) 6 (1–125) 6 (1–57) .35
Weight (kg) 3.28 0.65 3.24 0.54 .73
Weight  2.5 kg (n) 6 (15%) 23 (11%) .59
Shunt type <.001
Modified BT shunt 32 (78%) 199 (94%)
Central shunt 3 (7%) 11 (5%)
RVPA shunt 6 (15%) 2 (1%)
Indexed BT shunt diameter (mm/kg) 1.06 0.17 1.05 0.13 .72
Selective antegrade cerebral perfusion (n) 29 (71%) 172 (81%) .13
Cardiopulmonary bypass (min) 143 51 136 40 .30
Aortic crossclamp (min) 42 31 39 21 .50
DHCA (min) 23 34 17 28 .32
Myocardial ischemia (min) 65 19 56 19 .005
Total support time (min) 166 49 152 30 .10
Delayed sternal closure (n) 9 (22%) 24 (11%) .064
Postoperative course
Ventilation (h) 67 (27–528) 71 (15–1191) .36
Inotropic support (h) 47 (13–240) 48 (4–575) .87
Afterload reduction (h) 72 (24–213) 72 (4–696) .78
Cardiac complications (n) 17 (42%) 84 (37%) .82
Noncardiac complications (n) 7 (17%) 41 (19%) .74
Second-stage procedure
Hemifontan (n) 31 (76%) 168 (79%)
Biventricular repair (n) 5 (12%) NA
More than moderate systemic AVVR (n) 2 (6%) 19 (11%) .38
Median age second-step procedure (mo) 5.0 (1.3–34.5) 4.0 (1.1–45.1) .001
HLHS, Hypoplastic left heart syndrome; NA, not applicable; RVPA, right ventricle to pulmonary artery;DHCA, deep hypothermic circulatory arrest; AVVR, atrioventricular valve
regurgitation; BT, Blalock–Taussig.
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referred to reoperation, all patients underwent balloon an-
gioplasty. Restenosis after balloon angioplasty occurred in
4 patients of the non-HLHS group, which was addressed
by repeat balloon angioplasty first. However, 2 patients un-
derwent aortic arch reconstruction during the second oper-
ative step because of a residual gradient. In the HLHSTABLE 3. Univariate risk factor analysis for early mortality after the
Norwood procedure
Risk factor OR (95% CI) P value
Gender female 2.05 (0.96–4.37) .060
Prematurity 1.59 (0.43–5.89) .45
Non-HLHS 0.52 (0.15–1.79) .29
Systemic right ventricle 3.81 (0.50–29.14) .25
Aberrant right subclavian artery 3.09 (1.02–9.37) .037
Anomalous pulmonary venous return 3.86 (0.91–16.29) .084
Diameter ascending aorta  2 mm 2.04 (0.90–4.66) .085
Weight at operation  2.5 kg 2.08 (0.77–5.59) .14
Use of DHCA 2.43 (1.08–5.46) .028
Duration of TSPT (per 15-min increase) 1.18 (1.03–1.36) .019
Duration of MI (per 15-min increase) 1.47 (1.11–1.94) .007
OR, Odds ratio; CI, confidence interval; HLHS, hypoplastic left heart syndrome;
DHCA, deep hypothermic circulatory arrest; TSPT, total support time;MI, myocardial
ischemia.
The Journal of Thoracic and Cagroup, restenosis was detected in 3 cases before the hemi-
Fontan operation.
Second-Stage Procedure
Overall, 204 patients underwent a subsequent second-
stage procedure. A hemi-Fontan operation was performed
in 31 patients in the non-HLHS group, and biventricular re-
pair with a Rastelli type of operation (VSD closure and
placement of RVPA conduit) was achieved in 4 patients
with aortic atresia and VSD and in 1 patient with a dou-
ble-outlet right ventricle. Two of the remaining 4 patients
with aortic atresia had VSDs that were not suitable for
a Rastelli operation because of their location. In the 2 other
cases, borderline left ventricular size was the reason for
a univentricular approach. All remaining 3 cases with
double-outlet right ventricle had severe left ventricular
hypoplasia prohibiting biventricular repair. Both patients
with transposition of the great arteries had a hypoplastic,
non-apex–forming right ventricle, and a biventricular ap-
proach was not possible.
At the end of follow-up, 168 patients in the HLHS group
had undergone a hemi-Fontan operation. Age at the hemi-
Fontan operation was 4.7 (1.3–16.7) months in the non-
HLHS group and 4.0 (1.1–45.1) months in the HLHS grouprdiovascular Surgery c Volume 144, Number 1 169
FIGURE 1. Kaplan–Meier estimated transplant-free survival after the Norwood operation compared between the non-HLHS and HLHS groups and
between patients with a systemic right ventricle and patients with a systemic left ventricle or substantial left ventricle remnant. LV, Left ventricle;
HLHS, hypoplastic left heart syndrome; RV, right ventricle.
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went operation at a median age of 21.2 (5.8–34.5) months.
Early death after the second-stage procedure occurred in 2
patients in the non-HLHS group and 7 patients in the
HLHS group (P ¼ .66).
Survival Analysis
Follow-up after the Norwood procedurewas complete for
all but 1 of the 186 surviving patients with a median of 6.2
(0.3-15.1) years. In the non-HLHSgroup, 1 patientwaswait-
ing for a hemi-Fontan operation and 1 patient was lost to
follow-up. In the HLHS group, 1 patient received a heart
transplant after the Norwood operation and 2 patients re-
ceived a heart transplant after the hemi-Fontan procedure.
One patient was not suitable for the creation of a Fontan
pathway and underwent multiple shunt replacements. Inter-
stage death between the hemi-Fontan operation and the Fon-
tan completion occurred in 8 patients in the HLHS group.
Until the end of follow-up, 22 patients in the non-HLHS
group and 108 patients in the HLHS group had proceeded
to completion of the Fontan circulation with no early deaths,
but 1 late death in the non-HLHS group and 4 late deaths in
the HLHS group. Overall, 50 patients were awaiting Fontan
completion. All patients who had biventricular repair were
alive at the end of the follow-up period.
The 5 patients who underwent biventricular repair were
excluded from analysis of long-term outcome. Transplant-
free survival was not statistically different between the
HLHS and the non-HLHS groups (P ¼ .119), and trended
to be higher in patients with a systemic left or substantial
left ventricle remnant contributing to cardiac output
(P ¼ .082) (Figure 1).
Transplant-free survival after the second surgical step
was not different between the non-HLHS and HLHS groups170 The Journal of Thoracic and Cardiovascular Surg(P¼ .69) and between cases with a morphologic right or left
systemic ventricle (P ¼ .46).
DISCUSSION
Congenital heart defects with single-ventricle physiology
and systemic outflow tract obstruction other than HLHS re-
quiring a Norwood operation are relatively rare, and
alternative surgical approaches, such as pulmonary artery
banding together with aortic arch repair, subaortic resection,
or palliative arterial switch operation, have been de-
scribed.13,14 Only 16% of our patients who underwent
a Norwood operation in the last 15 years were classified as
‘‘non-HLHS,’’ and the underlying anatomy showed great
variability. The main finding of our study was that the
Norwood operation can be applied with good short- and
long-term results regardless of the underlying anatomy
and ventricular morphology.
In our cohort, minor differences in surgical technique ex-
isted between the HLHS and non-HLHS groups. Pulmonary
blood flow is routinely provided by a Blalock–Taussig
shunt. The RVPA shunt is avoided because of potential dis-
advantages from a ventriculotomy of the systemic right ven-
tricle. In non-HLHS cases with a hypoplastic residual outlet
chamber connected to the systemic ventricle by an unre-
strictive VSD, an RVPA shunt can be placed without poten-
tially harming the systemic ventricle. This explains the
more frequent use in the non-HLHS group.
The construction of the neoaorta can be more complex
with transposed great arteries. Different techniques includ-
ing transection of both vessels, pulmonary artery and as-
cending aorta, or techniques using 2 patches to avoid
a single spiral-shaped patch have been described.8,15,16
We prefer a single patch to avoid multiple anastomotic
sites. Recurrent aortic arch obstruction in patients withery c July 2012
Hansen et al Congenital Heart Disease
C
H
Dtransposition of the great arteries tended to be less frequent
compared with the remaining patients in the non-HLHS
group. However, it is a relatively common problem after
the Norwood procedure and affects approximately 20% of
the cases varying on the definition applied.17,18 The cause
is most likely multifactorial and influenced by the surgical
technique, type of patch material, and residual ductal
tissue in the distal arch.19 In our cohort, recurrent aortic
arch obstruction was diagnosed in 19% of patients in the
HLHS group and 38% of patients in the non-HLHS group.
No differences regarding the resection of the ductal tissue
existed. In contrast with our patients in the HLHS group
who only developed restenosis of the distal aortic arch, ste-
nosis of the neoascending aorta or the proximal aortic arch
was detected in 4 patients in the non-HLHS group, which ex-
plains the higher incidence of recurrent aortic arch
obstruction.
Our study showed that early survival was not different be-
tween the non-HLHS and HLHS groups, and that a systemic
right ventriclewas not associated with a higher risk for early
failure. In addition, postoperative outcome parameters, such
as frequency of postoperative complications, duration of
mechanical ventilation, and length of vasoactive drug ther-
apy, were not different between the non-HLHS and HLHS
groups. Several previous studies evaluated the outcome after
the Norwood procedure for complex single-ventricle le-
sions. Jacobs and colleauges8 compared their single-center
experience with the Norwood operation between children
with HLHS and patients with related malformations; they
found that right ventricular dominancewas a significant pre-
dictor ofmortality. Daebritz and colleagues9 reported higher
operative survival in a group of 63 patientswith other lesions
than HLHS compared with 131 patients with HLHS. They
hypothesized that a morphologic left systemic ventricle
was contributing to higher survival in the non-HLHS group.
In agreement with our results, 2 other studies did not find
a significant difference in operative survival between pa-
tients with other forms of single-ventricle physiology and
patients with HLHS undergoing theNorwood procedure.4,16
The outcome after the Norwood operation in 37 patients
with transposition of the aorta and functional single left
ventricle was not different compared with patients with
HLHS in a study conducted byLotto and colleagues.20 In ad-
dition to the presence of a single right ventricle, various
other risk factors for higher hospital mortality after the Nor-
wood procedure have been reported.1-5,16 In our cohort, the
only patient-related risk factor was the presence of an aber-
rant right subclavianartery.Prematurity,HLHSor a systemic
right ventricle, an ascending aorta diameter of 2 mm or less,
and low weight at operation were not found to increase the
risk for early failure after Norwood operation. As procedural
risk factors, the use of DHCA and longer duration of total
support time and myocardial ischemia were associated
with a higher risk for early death.The Journal of Thoracic and CaInterstage mortality after the Norwood operation is still
a concern and occurred in 15 patients of the HLHS group
but was not present in the non-HLHS group. As a conse-
quence, survival up to superior cavopulmonary anastomosis
trended to be lower in the HLHS group. The physiology of
the Norwood circulation is the same for those with non-
HLHS and HLHS. The volume load for the systemic ventri-
cle is increased because of shunt-dependent pulmonary
blood flow. In the non-HLHS group, 63% had a systemic
left ventricle or 2 relatively well-developed ventricles,
which might be more capable of coping with the volume
overload and the exposure to systemic pressures.
Five patients in the non-HLHS group underwent biven-
tricular repair. A subsequent biventricular repair may be
an option for patients who have an adequate mitral valve
and left ventricular dimensions at the time of second-
stage surgery, usually in the presence of a VSD. Although
staged biventricular repair seems to be a relatively safe op-
tion for this small subset of patients, early relief of cyanosis,
shunt-independent pulmonary blood flow, and reduction of
volume load are arguments for primary repair, which can be
performed alternatively with low mortality.21,22
In our single-center experience, long-term outcome was
not different between the non-HLHS and HLHS groups.
However, the impact of ventricular morphology on long-
term outcome in patients with a single ventricle is an ongo-
ing debate. In our cohort, overall survival in patients with
a systemic left ventricle only trended to be higher compared
with cases with a right systemic ventricle. This can be attrib-
uted to mortality between the Norwood operation and the
second operative step. Thereafter, survival was not different.
Recent studies evaluating the long-term outcome after the
Fontan operation also reported that ventricular morphology
has no impact on survival after Fontan completion.23,24
These studies also included patients without a prior
Norwood operation. All these results are encouraging for
the treatment of single-ventricle lesions with a systemic
right ventricle.
Limitations
Limitations of our study are characterized by the retro-
spective design and the relatively small number of patients
in the non-HLHS group. All comparisons are made on the
basis of observational, nonrandomized data.
CONCLUSIONS
Our single-center experience shows that in the current
era, the Norwood operation can be performed for complex
single-ventricle lesions with similarly good short- and
long-term outcomes regardless of the underlying anatomy.
These results are encouraging for the treatment of single-
ventricle lesions with a systemic right ventricle. The higher
incidence of recurrent aortic arch obstruction in the non-
HLHS group can be explained by the presence of additionalrdiovascular Surgery c Volume 144, Number 1 171
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Dproximal aortic arch obstruction, which was not found in the
HLHS group.
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